Santé & Pharma

Gabather AB

18,3M

Gain Therapeutics, Inc.

77,6M

Galderma Group AG

45,5B

Galectin Therapeutics INC

347,9M

Galecto, Inc.

Galenica AG

4,1B

Galera Therapeutics, Inc.

3,4B

Gamida Cell Ltd.

Garofalo Health Care

498M

Garofalo Health Care GHC Acquisisce LO Storico Gruppo Romano da CUI HA Tratto le SUE Origini / GHC Acquires the Historical Roman Group From Which IT Drew ITS Origins

482,1M

Garofalo Health Care Garofalo Health Care S.P.A. Acquisisce Casa di Cura Citta’ di Roma / Garofalo Health Care S.P.A. Acquires Casa di Cura Citta' di Roma

483,8M

Garofalo Health Care Garofalo Health Care S.p.a.: Assemblea Ordinaria e Straordinaria degli Azionisti / Ordinary and Extraordinary Shareholders' Meeting

483,8M

Garofalo Health Care Garofalo Health Care S.p.a.: Standard Ethics Alza IL Rating di Sostenibilita' / Standard Ethics Raises Sustainability Rating

482,1M

Garofalo Health Care Garofalo Health Care S.p.a.: Standard Ethics Conferma IL Rating ESG di Breve e Medio/lungo Termine / Standard Ethics Confirms Short-Term and Medium/long-Term ESG Ratings

483,8M

Garofalo Health Care SPA

498M

Gelesis Holdings, INC.

Gemini Therapeutics, Inc. /DE

Gemini Therapeutics, Inc. /DE

GeneDx Holdings Corp.

2,3B

Generation Bio Co.

Genesis Healthcare, Inc.

15,7B

Genky DrugStores株式会社

113,8B

Genmab A/S

124,6B

Genocea Biosciences, INC.

5,9k

Genomtec S.A.

69,8M

Genovis A/B

1,3B

Genovis A/B

1,3B

Genovis AB

1,3B

Gens Global株式会社

19,1M

Genscript Biotech Corporation

50,2B

Gentian Diagnostics ASA

629,2M

Genufood Energy Enzymes Corp.

80,9k

GeoVax Labs, Inc.

5,2M

Gerresheimer AG

908,4M

Getinge AB

64,6B

Getinge AB

64,6B

Gilead Sciences INC

162,3B

Gilead Sciences, INC.

165,2B

Ginkgo Bioworks Holdings, Inc.

Gland Pharma Limited

409,5B

Glenmark Pharmaceuticals Limited

631,7B

Global Blood Therapeutics, Inc.

Global Cosmed S.A.

Globus Medical INC

11,2B

Glycomimetics INC

GoHealth, Inc.

8,9M

Good Fellow Healthcare Holdings Ltd.

76,7M

GoodRx Holdings, Inc.

1,3B

Gossamer Bio, Inc.

75,7M

Grand Pharmaceutical Group Ltd.

18,9B